Palisade Bio (PALI)
(Delayed Data from NSDQ)
$4.42 USD
-0.05 (-1.12%)
Updated Jul 9, 2024 03:56 PM ET
After-Market: $4.43 +0.01 (0.23%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PALI 4.42 -0.05(-1.12%)
Will PALI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PALI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PALI
Bears are Losing Control Over Palisade Bio (PALI), Here's Why It's a 'Buy' Now
Palisade (PALI) In-Licenses Rights for IBD Candidate, Stock Up
PALI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Palisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Palisade Bio, Inc. (PALI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Palisade (PALI) Enrolls First Patient in LB1148 Study in China
Other News for PALI
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
Palisade Bio provides update on collaboration with Strand Life Sciences
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
Palisade Bio gets notice of allowance for Canadian patent covering lead product candidate